Research has shown that gain‐of‐function mutations in PIK3CA (the gene encoding p110α, the catalytic subunit) are linked to the overactivation of PI3K, a key mechanism in oncogenesis, especially in breast cancer [4, 25]. This evidence concerns the gene PIK3CA and breast carcinoma.